To be considered for the State Technological Invention Award, the invention must fulfill the following criteria:
- It is new and has not yet been made public;
- The invention must have technical superiority and is creative.
- The invention creates significant economic benefits or social benefits.
Usually inventions submitted for the award consideration have already been granted patents.
This year, a new medicine, Antofloxacin Hydrochloride, led by Shanghai Institute of Materia Medica researcher YANG Yushe, received the Second Class Award.
The medicine, with almost no phototoxicity and much less cardiotoxicity than similar medicines, helps to treat various diseases related to bacterial infection. It's China's first new medicine with independent intellectual property rights since 1993.
The clinical research found that the efficacy of this medicine reached 98.8 percent, with only 1.2 per cent of patients showing side effects in IV phase clinical trials, much lower than its counterparts. By the end of 2016, the medicine had entered 150 hospitals and medical institutions in 22 provinces and municipalities and was included in the medical insurance medicine list in more than ten of these areas.
Three other agricultural inventions also won the Second Class Award in this category.
Click here for the complete issue.